A Prospective, Multicenter, Randomized, Double-Blind Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With the Oral Contraceptive Regimen DR-1021
Phase of Trial: Phase III
Latest Information Update: 17 Jul 2014
At a glance
- Drugs Ethinylestradiol/desogestrel (Primary)
- Indications Pregnancy
- Focus Pharmacodynamics
- Sponsors Barr Pharmaceuticals; Duramed Pharmaceuticals Inc
- 07 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Nov 2007 New trial record.